An observational study in Erectile Dysfunction and Premature Ejaculation, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Ondokuz Mayıs University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Erectile Dysfunction with a site in Turkey — 6 open to participants now, 8 under way, 2 of them phase 3. Erectile Dysfunction · Turkey.
Among the 32 studies in Erectile Dysfunction with a site in Turkey, this one is the 4th largest by enrollment of the 15 observational ones that give a count, is one of 5 that started in 2026, is one of 15 observational ones, and was the 32nd registered.
702 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.
Browse Erectile Dysfunction studies →6 of the 32 studies in Erectile Dysfunction with a site in Turkey are open now. Recruiting first, the newest first:
Uskudar University · Sites in Turkey
Ages 25–45 · Men only · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 25–75 · Men only
Varol TUNALI · Sites in Turkey
Ages 30–65 · Men only
Haseki Training and Research Hospital · Sites in Turkey
Ages 18+ · Men only
Medipol University · Sites in Turkey
Ages 45–75 · Men only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger; 2 take children under 18; 7 take healthy volunteers.
This study: 18 Years to 40 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3 · Phase 4 5
First in 2002; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 253 is above the median of 133 across 126 observational studies indexed under Erectile Dysfunction.
Median enrollment 60 across the 17 interventional studies, 130 across the 15 observational. Of the 20 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 32 have an industry lead sponsor. The 10 most frequent:
Ondokuz Mayıs University is the lead sponsor of 281 studies on the registry; 64 are open to participants now.
Ondokuz Mayıs University has 1 study filed under Erectile Dysfunction — fewer than ten, so there is no comparison to draw.
2 of the studies in Erectile Dysfunction with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07707505Medipol UniversityIntracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile Dysfunction | 2027-01-01 |
| NCT07761546Varol TUNALIAIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism | 2027-04-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Erectile Dysfunction with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This single-center cross-sectional study aims to determine the prevalence of erectile dysfunction and premature ejaculation in sexually active men aged 18 to 40 years and to evaluate their association with depressive and anxiety symptoms, lifestyle factors, and sociodemographic characteristics. Participants attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups completed a structured questionnaire, the International Index of Erectile Function-15 (IIEF-15), the Premature Ejaculation Diagnostic Tool (PEDT), the Beck Depression Inventory, and the Generalized Anxiety Disorder-7 (GAD-7) scale.
Sexually active men aged 18 to 40 years attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups.
Inclusion Criteria:
Exclusion Criteria:
Exclusion Criteria:
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Men attending outpatient clinics for routine health check-ups who completed IIEF-15, PEDT, Beck Depression Inventory and GAD-7.
Prevalence of erectile dysfunction
Proportion of participants with an IIEF-15 erectile function domain score of 25 or lower.
Time frame: At enrollment (single cross-sectional assessment)
Prevalence of premature ejaculation
Proportion of participants with a PEDT total score of 11 or higher.
Time frame: At enrollment (single cross-sectional assessment)
Association of anxiety symptoms with sexual dysfunction
Association of GAD-7 score (10 or higher defined as anxiety) with erectile dysfunction and premature ejaculation.
Time frame: At enrollment
Association of depressive symptoms with sexual dysfunction
Association of Beck Depression Inventory score (17 or higher defined as depression) with erectile dysfunction and premature ejaculation.
Time frame: At enrollment
Association of lifestyle and sociodemographic factors with sexual dysfunction
Association of BMI, waist circumference, smoking, alcohol use, physical activity, working pattern, weekly working hours, education, income and marital status with erectile dysfunction and premature ejaculation.
Time frame: At enrollment
Plan to share: No — Individual participant data will not be shared publicly as participant consent did not include public data sharing.
No publications or documents are linked to this record.
Ran from May 2026 to primary completion in Jul 2026, 2 months.
Of 41 observational studies under Erectile Dysfunction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 77. This study's 2 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.